Close Menu

NEW YORK – Todos Medical announced on Monday a development and commercialization partnership with Singapore-based Pathnova for Todos' breast cancer and SARS-CoV-2 diagnostic kits.

Pathnova, a spinout of Temasek Life Sciences Laboratory, will further develop and commercialize Todos' tests in Singapore, while Todos will assist Pathnova to commercialize its nasopharyngeal cancer tests through its affiliates in the US and Singapore.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.